A Billion Dollar Recovery for Investors and Accountability from Wall Street
In re American International Group, Inc. Securities Litigation
Coal Mine Safety Cover-Up Exposed, Resulting in a $265 Million All-Cash Settlement
In re Massey Energy Co. Securities Litigation
A $170 Million Recovery for Investors after Fannie Mae’s House of Cards Collapses
In re Fannie Mae 2008 Securities Litigation
Rocket Docket Case of Accounting Fraud Lands a $97.5 Million Recovery
In re Computer Sciences Corporation Securities Litigation
A Tainted Mining Merger Unearthed, Resulting in One of the Largest Settlements in Court of Chancery History.
In re Freeport-McMoRan Copper & Gold Inc. Derivative Litigation
Capturing the Crown Jewel of the Credit Crisis: $275 Million with Bear Stearns and $19.9 Million with Auditor Deloitte & Touche
In re Bear Stearns Cos. Inc. Securities Litigation
With Recoveries of $671 Million, HealthSouth Set New Lows for Corporate Conduct. And Record Highs for the Ability of Litigation to Even the Score.
In re HealthSouth Securities Litigation
$624 Million...One of the Largest Securities Settlements Against a Principal Architect of the Mortgage Crisis
In re Countrywide Financial Corporation Securities Litigation
A Global Price-Fixing Scheme with 50 Defendants Spanning Six Continents with more than $1 Billion Recovered
In re Air Cargo Shipping Services Antitrust Litigation
Achieving Extraordinary Results Across Borders in an Egregious Case of Securities Fraud
In re Satyam Computer Services Ltd. Securities Litigation
The REAL Deal: The First Case Tried to a Jury Verdict Following the Enactment of the PSLRA: A Landmark Victory. A Firm of Firsts.
In re Real Estate Associates Limited Partnership Litigation
Successful Class Actions Against Mutual Funds are Rare---and a Combined Recovery of $100 Million for Investors to Boot
In re Oppenheimer Champion Fund Securities Fraud Class Action and In re Core Bond Fund
A $300 Million Victory and One of the Largest Secured During the Earliest Stages of a Securities Class Action
In re General Motors Corp. Securities Litigation
A Message for Big Pharma: A 400% Price Hike on Life-Changing Medication? Anticompetitive. And Unconscionable.
In re Abbott Laboratories Norvir Antitrust Litigation
When a Pharma Giant's Quest for Blockbuster Drug Profits Threatened Shareholders and Consumers Alike, We Fought Back. And Won.
In re Bristol-Myers Squibb Securities Litigation
Class Action Forces Corporate Wrongdoer to Come Clean
In re Waste Management, Inc. Securities Litigation
$80 Million Settlement and Significant Corporate Governance Reforms - That's How We Respond to a Corporate Culture of Misconduct
In re Vesta Insurance Group, Inc. Securities Litigation